2nd Quarter - Report

340B HEALTH for 340B HEALTH

Firm
Client
Income
—
Expenses
$208,756
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

HR 2606 and S 1376. Extending 340B Drug Pricing to Inpatient Drugs and improving program integrity Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs

LobbyistCovered position, as disclosed
DHRUBAJYOTI BHATTACHARYA (No longer with organization)
MARISA SCHRADER CONWAY —
ANNA MANGUM LA for Rep. Viscloskey and Fascell 1988-91
ROBERT RECKLAUS Chief of Staff for Rep. Carolyn McCarthy 02-08
TED SLAFSKY Fellow for Sen. Democratic Policy Comm 1994
JAIMIE VICKERY New LA for Reps Horn and Biggert 2000-2005
WILLIAM VON OEHSEN —
BONNIE WEINTRAUB New —

Contacted: Health Resources & Services Administration (HRSA); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2606 (110th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.